| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/26/2001 | WO2001045729A8 A novel polypeptide-human ribosomal phosphoprotein 16 and the polynucleotide encoding said polypeptide |
| 07/26/2001 | WO2001034206A8 Nucleic acid-containing complex |
| 07/26/2001 | WO2001018212A3 Mycobacterium paratuberculosis-specific antigens and their diagnostic uses |
| 07/26/2001 | WO2001017548A3 Use of natriuretic peptides as antibiotically effective substances for treating bacterial infections |
| 07/26/2001 | WO2001017543A3 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 07/26/2001 | WO2001015726A3 Compositions for stimulating cytokine secretion and inducing an immune response |
| 07/26/2001 | WO2001014415A3 Egfh2 genes and gene products |
| 07/26/2001 | WO2001013891A3 Modulation of release from dry powder formulations |
| 07/26/2001 | WO2001010902A8 Nucleoc acids and secreted polypeptides encoded thereby |
| 07/26/2001 | WO2001004264A3 Atherosclerosis-associated genes |
| 07/26/2001 | WO2001003718A3 Combination chemotherapy |
| 07/26/2001 | WO2001002601A3 Cell-based assay systems for examining hcv ns3 protease activity |
| 07/26/2001 | WO2001001748A3 Peptide compounds that bind her2 |
| 07/26/2001 | WO2001000784A3 Compound derived from an offset orf of the ice gene |
| 07/26/2001 | WO2000078933A3 Novel calpains and their use |
| 07/26/2001 | WO2000078803A3 Use of eif4e binding agents in therapy |
| 07/26/2001 | WO2000075336A3 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines |
| 07/26/2001 | WO2000075180A3 Peptides for vaccinating against human cmv |
| 07/26/2001 | WO2000074711A3 10-formyltetrahydrofolate dehydrogenase as therapeutical agent |
| 07/26/2001 | WO2000070341A3 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/26/2001 | WO2000066156A8 Death domain containing receptor 5 |
| 07/26/2001 | WO2000061613A9 Channel forming toxins as antiviral agents |
| 07/26/2001 | WO2000055194A9 Tuberculosis antigens and methods of use therefor |
| 07/26/2001 | WO2000044356A9 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same |
| 07/26/2001 | WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/26/2001 | WO2000040616A9 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/26/2001 | WO2000017361A3 Interferon-epsilon |
| 07/26/2001 | WO1999064040A8 Novel polyene macrolide compounds and uses |
| 07/26/2001 | US20010009920 Combination therapy for osteoporosis |
| 07/26/2001 | US20010009905 Adipocyte Complement-Related Protein encoded polypeptides, used in therapy and diagnosis, cell proliferation, cell death, energy homestasis; treatment of cancers, obesity, diabetes, heart disease, immunity |
| 07/26/2001 | US20010009901 Antineoplastic peptides |
| 07/26/2001 | US20010009900 Breast cancer, increase insulin receptor phosphorylation in Type II diabetics |
| 07/26/2001 | US20010009899 Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects |
| 07/26/2001 | US20010009898 Protein V binding to immunoglobulin G, obtained from Gardnerella vaginalis |
| 07/26/2001 | US20010009772 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides |
| 07/26/2001 | US20010009768 Polynucleotides encoding cytokine designated LERK-5 |
| 07/26/2001 | US20010009766 Dna encoding galanin galr3 receptors and uses thereof |
| 07/26/2001 | US20010009764 Endothelial-derived toxic factor |
| 07/26/2001 | US20010009681 Methods of use for dietary compositions comprising lactoferrin and colostrum |
| 07/26/2001 | US20010009675 Keratin-based hydrogel for biomedical applications and method of production |
| 07/26/2001 | DE19961141A1 Pharmazeutische Zusammensetzung aus Spinnengiften sowie deren Herstellung und Verwendung zur Behandlung von Tumorerkrankungen The pharmaceutical composition of spider venoms as well as their preparation and use for the treatment of tumor diseases |
| 07/26/2001 | DE19953167A1 Mit TRP-Proteinen verwandtes Protein MTR1 und dieses codierende DNA-Sequenz With TRP proteins related protein MTR1 and this DNA sequence encoding |
| 07/26/2001 | DE10002200A1 Treatment of erectile dysfunction by administration of a stimulator of guanylate cyclase, e.g. C-Type natriuretic polypeptide, optionally with a phosphodiesterase inhibitor |
| 07/26/2001 | DE10001113A1 Recombinant human histone protein, useful e.g. as anticancer or antibiotic agent, expressed in prokaryotic cells |
| 07/26/2001 | CA2743326A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398343A1 Virus strains for the oncolytic treatment of cancer |
| 07/26/2001 | CA2398256A1 Methods for detecting cancer of the central nervous system |
| 07/26/2001 | CA2398083A1 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
| 07/26/2001 | CA2397919A1 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
| 07/26/2001 | CA2397896A1 Human sperm specific lysozyme-like proteins |
| 07/26/2001 | CA2397838A1 Sperm specific proteins |
| 07/26/2001 | CA2397835A1 Polypeptides with therapeutic activity and methods of use |
| 07/26/2001 | CA2397833A1 Novel haptotactic peptides |
| 07/26/2001 | CA2397830A1 Compositions for the prevention of diaper dermatitis |
| 07/26/2001 | CA2397802A1 Calcilytic compounds |
| 07/26/2001 | CA2397793A1 Combination of temozolomide and pegylated interferon-alpha for treating cancer |
| 07/26/2001 | CA2397783A1 Human gaba receptor proteins and polynucleotides encoding the same |
| 07/26/2001 | CA2397774A1 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | CA2397733A1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension |
| 07/26/2001 | CA2397617A1 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 07/26/2001 | CA2397571A1 Apoptin-associating protein |
| 07/26/2001 | CA2397543A1 Gamma-secretase inhibitors |
| 07/26/2001 | CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
| 07/26/2001 | CA2397205A1 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/26/2001 | CA2397202A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
| 07/26/2001 | CA2397065A1 Compositions for delivery of a cortisol antagonist |
| 07/26/2001 | CA2396995A1 Treatment of uv induced immunosuppression |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2396935A1 Phosphatases |
| 07/26/2001 | CA2396697A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
| 07/26/2001 | CA2396381A1 Nasally administrable cyclic peptide compositions |
| 07/26/2001 | CA2396307A1 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 07/26/2001 | CA2396283A1 Human cystine knot polypeptide |
| 07/26/2001 | CA2395855A1 Recombinant flaviviruses and methods of use thereof |
| 07/26/2001 | CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395763A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 07/26/2001 | CA2395736A1 Novel nucleic acids and polypeptides |
| 07/26/2001 | CA2395489A1 Process for the purification of antothrombin-iii |
| 07/26/2001 | CA2395443A1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2394753A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2332214A1 Compositions and methods for treating osteoporosis and lowering cholesterol |
| 07/25/2001 | EP1118668A1 Transduction of recombinases for inducible gene targeting |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118662A2 Apoptin-associating protein |
| 07/25/2001 | EP1118660A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 07/25/2001 | EP1118659A1 Expression systems for functional nucleic acid expression |
| 07/25/2001 | EP1118621A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1118330A1 Interferon-alpha use in the treatment of Ewing's family of tumors |
| 07/25/2001 | EP1118329A1 Lacrimal secretion promoters or eye drops for treating keratoconjunctival failure containing as the active ingredient natriuretic peptides |
| 07/25/2001 | EP1117837A2 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 07/25/2001 | EP1117836A2 Expressionanalysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 07/25/2001 | EP1117824A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
| 07/25/2001 | EP1117817A2 Therapeutically active proteins in plants |
| 07/25/2001 | EP1117805A2 Modified tgf-beta superfamily proteins |
| 07/25/2001 | EP1117804A2 Chimaeric proteins between members of tgf-beta superfamily |
| 07/25/2001 | EP1117803A1 Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus |